Intellipharmaceutics International Inc. (IPCI)

[Amigo Mike]

Cysonic.

You post the news about the new lawsuits against opioid manufacturers. Those lawsuits are driven by the opioid addiction problem and the manufacturers aggressive marketing of those drugs.

Then you jump to PODRAS, which is not a solution to opioid addiction, and indicate that we'll have a bidding war if it works. Addiction and overdose prevention are not the same things. Were IPCI's Rexista a non addictive pain medication, that would fit. However there are no such claims regarding Rexista being non addictive.

I agree that PODRAS confirmation does add value to the company once human trials are in play ..... but can't jump from addiction to PODRAS making it sound like there is some relationship between the two. There is not. Even the abuse deterrence aspect ..... DOES NOT PREVENT ADDICTION.

That all said, IMO, a key aspect of Rexista will be its release profile. As I understand it the release profile is different such that it may reduce the potential for that initial euphoric state when taken correctly, i.e. the initial loading dose release. Even there, doesn't prevent someone from taking Rexista PODRAS more frequently than prescribed and PODRAS does not kick in til a couple tablets are taken together so taking more than one could still produce that initial euphoric feeling and eventually addiction.

So until IPCI can say that Rexista or Rexista w/ PODRAS helps curb addiction, you cannot associate the two. PODRAS is overdose prevention .... NOT addiction prevention.

Amigo Mike